PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17005562-6	2006	CENTB1 expression in epithelial cells was highly induced by tumor necrosis factor alpha, interleukin 1beta, and the NOD1 and NOD2 ligands (gamma-d-glutamyl-meso-diaminopimelic acid and muramyl dipeptide, respectively).	N(2)-(gamma-D-glutamyl)-meso-2,2'-diaminopimelic acid	139-180	nucleotide binding oligomerization domain containing 2	Homo sapiens	125-129	
17005562-8	2006	Functionally, CENTB1 overexpression inhibited NOD1- and NOD2-dependent activation of NF-kappaB, whereas small inhibitory RNA against CENTB1 increased NF-kappaB activation following NOD1- or NOD2-mediated recognition of the bacterial components gamma-d-glutamyl-meso-diaminopimelic acid and muramyl dipeptide, respectively.	N(2)-(gamma-D-glutamyl)-meso-2,2'-diaminopimelic acid	244-285	nucleotide binding oligomerization domain containing 2	Homo sapiens	190-194	
31798878-2	2019	In this review, we summarise the discovery of two key peptidoglycan metabolites, gamma-d-glutamyl-meso-diaminopimelic acid (iE-DAP) and muramyl dipeptide and their respective receptors, Nod1 and Nod2, and review progress towards translating these findings into therapeutic agents.	N(2)-(gamma-D-glutamyl)-meso-2,2'-diaminopimelic acid	81-122	nucleotide binding oligomerization domain containing 2	Homo sapiens	195-199	
29165176-3	2017	Nucleotide-binding oligomerization domain-containing protein 1 and 2 (NOD1 and NOD2) are components of NLR family, and ligands of these factors are gamma-D-glutamyl-meso-diaminopimelic acid (iE-DAP) and muramyl dipeptide (MDP), respectively.	N(2)-(gamma-D-glutamyl)-meso-2,2'-diaminopimelic acid	148-189	nucleotide binding oligomerization domain containing 2	Homo sapiens	79-83